GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Other Gross PPE

Statera BioPharma (STU:7CB) Other Gross PPE : €1.03 Mil (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Other Gross PPE?

Statera BioPharma's Other Gross PPE for the quarter that ended in Sep. 2022 was €1.03 Mil.

Statera BioPharma's quarterly Other Gross PPE declined from Mar. 2022 (€1.21 Mil) to Jun. 2022 (€1.18 Mil) and declined from Jun. 2022 (€1.18 Mil) to Sep. 2022 (€1.03 Mil).

Statera BioPharma's annual Other Gross PPE increased from Dec. 2019 (€0.00 Mil) to Dec. 2020 (€0.08 Mil) and increased from Dec. 2020 (€0.08 Mil) to Dec. 2021 (€0.88 Mil).


Statera BioPharma Other Gross PPE Historical Data

The historical data trend for Statera BioPharma's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Other Gross PPE Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
Other Gross PPE
- 0.08 0.88

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.74 0.88 1.21 1.18 1.03

Statera BioPharma Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Statera BioPharma Business Description

Traded in Other Exchanges
N/A
Address
4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma Headlines

No Headlines